1-4 of 4
Parth Shah, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Generic Imatinib Compared to Glivec in Chronic Phase - Chronic Myeloid Leukemia-Single Center Retrospective Analysis

Seema Shrinivas Bhatwadekar, MDMDcine, Shubhangi Vishwas Deshpande, MD, Arpan Mehta, MD, Parth Shah, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4162.
https://doi.org/10.1182/blood-2019-126495
Published: 2019
Journal Articles

VISTA Is a Novel Regulator of Macrophage Biology

Parth Shah, MD, Mohamed Eltanbouly, BSc, Nicole Smits, Aurelien Sarde, Randolph Noelle, Rodwell Mabaera, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2320.
https://doi.org/10.1182/blood-2019-131310
Published: 2019
Journal Articles

Mutational Phasing: Clinical Relevance in Tyrosine Kinase Domain Mutations Using Next Generation Sequencing in Chronic Myeloid Leukemia

Seema S. Bhatwadekar, MD, Parth Shah, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4269.
https://doi.org/10.1182/blood-2018-99-114130
Published: 2018
Journal Articles

Retrospective Analysis of the HB A2 Value in Sickle Cell Positive Population in Central Gujarat, India

Seema S. Bhatwadekar, MD, Parth Shah, MD, Sandip Shah, MD, Harsukh Toprani, MD, Bijal Shah, MBBS,DCP, Devenkumar Desai, MBBS DCP, Bhagvanji B Zanzarukiya, MD, Tejas S Patel, MD, Tushar Toprani, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4789.
https://doi.org/10.1182/blood.V130.Suppl_1.4789.4789
Published: 2017